A 78-year-old man with non-valvular atrial fibrillation, hypertension and diabetes has a CHA2DS2-VA score of 3. He has normal renal function and is currently taking aspirin 100 mg daily. According to Australian AF guidelines, what is the most appropriate change to his antithrombotic therapy?